BusinessChromaDex Announces Closing of Second Tranche of the $25 Million Strategic Investment Led by Mr. Li Ka-shingBy Nasdaq OMXMay 25, 2017, 8:09 PM UTC
BusinessMedicare Coverage of Prolaris® Test Expands with the Addition of Men Diagnosed with Favorable Intermediate Risk Prostate CancerBy Nasdaq OMXMay 25, 2017, 2:40 PM UTC
BusinessMedicare Coverage of Prolaris® Test Expands with the Addition of Men Diagnosed with Favorable Intermediate Risk Prostate CancerBy Nasdaq OMXMay 25, 2017, 2:40 PM UTC
BusinessMedicare Coverage of Prolaris® Test Expands with the Addition of Men Diagnosed with Favorable Intermediate Risk Prostate CancerBy Nasdaq OMXMay 25, 2017, 2:40 PM UTC
BusinessEDAP Announces CMS Approval of New Reimbursement Code for HIFU Ablation of the ProstateBy Nasdaq OMXMay 22, 2017, 1:12 PM UTC
BusinessEDAP Announces CMS Approval of New Reimbursement Code for HIFU Ablation of the ProstateBy Nasdaq OMXMay 22, 2017, 1:12 PM UTC
BusinessEDAP Announces CMS Approval of New Reimbursement Code for HIFU Ablation of the ProstateBy Nasdaq OMXMay 22, 2017, 1:12 PM UTC
BusinessEDAP Announces CMS Approval of New Reimbursement Code for HIFU Ablation of the ProstateBy Nasdaq OMXMay 22, 2017, 1:12 PM UTC
